Urolyte Injection
Marketer
Neiss Labs Pvt Ltd
Salt Composition
Urokinase (500000IU/ml)
Overview Urolyte Injection
Thrombolytic Therapy with Urolyte Injection dissolves dangerous blood clots obstructing blood vessels. This treatment is indicated for patients recovering from myocardial infarction and is also employed in managing pulmonary embolism and stroke. Administration requires strict medical supervision; dosage and treatment length are determined individually by your physician, who will monitor your progress closely until stabilization. Potential side effects include nausea, vomiting, injection site hemorrhage, allergic responses, and hypotension. Increased bleeding risk is also a possibility. Your doctor will thoroughly discuss the benefits and risks before treatment begins. Continue all prescribed medications as directed, even after the Urolyte Injection. Pre-existing conditions such as bleeding disorders, renal or hepatic impairment, pregnancy, or breastfeeding, along with a complete medication list, must be disclosed to your physician to ensure safe and effective use.
Primary Ingredients of Urolyte Injection
There is no text provided to rephrase.
Uses of Urolyte Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Urolyte Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Urolyte Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Urolyte Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Urolyte Injection works:
Urolyte Injection clears obstructive blood clots within blood vessels, restoring circulation to compromised tissue and thus preventing necrosis and improving patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Urolyte Injection hasn't been established as safe. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of Urolyte Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Urolyte Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingNOT RELEVANT
Inapplicable, given Urolyte Injection's restricted use to inpatients.
KidneySAFE IF PRESCRIBED
Administering Urolyte Injection to individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is advised. Urolyte Injection is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should receive Urolyte Injection with close monitoring. Dosage modification of Urolyte Injection may be necessary. Physician consultation is advised.
What if you forget to take Urolyte Injection :
Should you forget a scheduled Urolyte Injection, seek your physician's advice.
Facts to Know About Urolyte Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide and Amino Acid Analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Early Thrombolytic Agents |
3,018 People bought this recently